Blockade of central beta-adrenergic receptors by tazolol (1-isopropylamino-3-(2-thiazoloxy)-2-propanol).
D000319:Adrenergic beta-Antagonists; D000526:Alprenolol / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors; D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects* / Q000378:metabolism; D000242:Cyclic AMP / Q000494:pharmacology; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D011412:Propanolamines / Q000494:pharmacology*; D011689:Purkinje Cells / Q000187:drug effects*; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D013844:Thiazoles / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D013844:Thiazoles; D000526:Alprenolol; C002268:tazolol; D000242:Cyclic AMP; D007545:Isoproterenol